The Use of the Polymerase Chain Reaction in the Detection, Quantification and Characterization of Human Retroviruses View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

1991

AUTHORS

Bernard J. Poiesz , Garth D. Ehrlich , Bruce C. Byrne , Keith Wells , Shirley Kwok , John Sninsky

ABSTRACT

Retroviruses are the etiologic agents of a host of diseases found in vertebrates. These include malignancies such as lymphomas, leukemias, sarcomas and carcinomas; autoimmune diseases such as arthritis and lupus; and cytopathic diseases leading to anemias and immune deficiency states. There are four well characterized human retroviruses (Figure 1). Human T-cell lymphoma/leukemia virus type I and II (HTLV-I and II) are oncornaviruses. HTLV-I is believed to be the etiologic agent of adult T-cell lymphoma/leukemia (ATLL) and a progressive neurological disorder formerly called tropical spastic paraparesis and now termed HTLV-I associated myelopathy (HAM) (Bhagavati et al. 1988; Ehrlich and Poiesz 1988; Poiesz et al. 1980). HTLV-I is also associated with immune deficiency. HTLV-I infection is endemic in Southern Japan, the Caribbean and Central Africa. In the United States, HTLV-I infection is most prevalent in the Southeastern section of the country among rural blacks, but is has also been identified in patients throughout America and appears to be increasing in prevalence among intravenous drug abusers (IVDA) (Ehrlich and Poiesz, 1988; Ratner and Poiesz, 1988). HTLV-II is approximately 65% homologous to HTLV-I (Kalyanaraman et al. 1982). It has been associated with rare cases of T-cell and hairy cell leukemias, but its exact disease association and endemic area of infection are unclear at this time. HTLV-II infection is also being diagnosed with greater frequency in American IVDA (Ehrlich et al. 1989). HTLV-V is a recently described retrovirus with limited homology to HTLV-I (Manzari et al. 1987). It has been identified in a few patients with CD4+ cutaneous T-cell lymphoma, but the virus has not been completely characterized and its disease association is poorly understood. More... »

PAGES

47-75

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-4684-5856-5_3

DOI

http://dx.doi.org/10.1007/978-1-4684-5856-5_3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1002987387


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Hematology/Oncology, Health Science Center, State University of New York, 13210, Syracuse, New York, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Division of Hematology/Oncology, Health Science Center, State University of New York, 13210, Syracuse, New York, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Poiesz", 
        "givenName": "Bernard J.", 
        "id": "sg:person.014430643177.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014430643177.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Hematology/Oncology, Health Science Center, State University of New York, 13210, Syracuse, New York, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Division of Hematology/Oncology, Health Science Center, State University of New York, 13210, Syracuse, New York, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ehrlich", 
        "givenName": "Garth D.", 
        "id": "sg:person.01324252605.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01324252605.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Hematology/Oncology, Health Science Center, State University of New York, 13210, Syracuse, New York, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Division of Hematology/Oncology, Health Science Center, State University of New York, 13210, Syracuse, New York, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Byrne", 
        "givenName": "Bruce C.", 
        "id": "sg:person.01277046301.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277046301.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Hematology/Oncology, Health Science Center, State University of New York, 13210, Syracuse, New York, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Division of Hematology/Oncology, Health Science Center, State University of New York, 13210, Syracuse, New York, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wells", 
        "givenName": "Keith", 
        "id": "sg:person.0723522010.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723522010.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cetus Corporation, 1400 Fifty Third Street, 94608, Emeryville, California, USA", 
          "id": "http://www.grid.ac/institutes/grid.418424.f", 
          "name": [
            "Cetus Corporation, 1400 Fifty Third Street, 94608, Emeryville, California, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kwok", 
        "givenName": "Shirley", 
        "id": "sg:person.01027656121.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01027656121.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cetus Corporation, 1400 Fifty Third Street, 94608, Emeryville, California, USA", 
          "id": "http://www.grid.ac/institutes/grid.418424.f", 
          "name": [
            "Cetus Corporation, 1400 Fifty Third Street, 94608, Emeryville, California, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sninsky", 
        "givenName": "John", 
        "id": "sg:person.0632555710.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632555710.46"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1991", 
    "datePublishedReg": "1991-01-01", 
    "description": "Retroviruses are the etiologic agents of a host of diseases found in vertebrates. These include malignancies such as lymphomas, leukemias, sarcomas and carcinomas; autoimmune diseases such as arthritis and lupus; and cytopathic diseases leading to anemias and immune deficiency states. There are four well characterized human retroviruses (Figure 1). Human T-cell lymphoma/leukemia virus type I and II (HTLV-I and II) are oncornaviruses. HTLV-I is believed to be the etiologic agent of adult T-cell lymphoma/leukemia (ATLL) and a progressive neurological disorder formerly called tropical spastic paraparesis and now termed HTLV-I associated myelopathy (HAM) (Bhagavati et al. 1988; Ehrlich and Poiesz 1988; Poiesz et al. 1980). HTLV-I is also associated with immune deficiency. HTLV-I infection is endemic in Southern Japan, the Caribbean and Central Africa. In the United States, HTLV-I infection is most prevalent in the Southeastern section of the country among rural blacks, but is has also been identified in patients throughout America and appears to be increasing in prevalence among intravenous drug abusers (IVDA) (Ehrlich and Poiesz, 1988; Ratner and Poiesz, 1988). HTLV-II is approximately 65% homologous to HTLV-I (Kalyanaraman et al. 1982). It has been associated with rare cases of T-cell and hairy cell leukemias, but its exact disease association and endemic area of infection are unclear at this time. HTLV-II infection is also being diagnosed with greater frequency in American IVDA (Ehrlich et al. 1989). HTLV-V is a recently described retrovirus with limited homology to HTLV-I (Manzari et al. 1987). It has been identified in a few patients with CD4+ cutaneous T-cell lymphoma, but the virus has not been completely characterized and its disease association is poorly understood.", 
    "editor": [
      {
        "familyName": "de la Maza", 
        "givenName": "Luis M.", 
        "type": "Person"
      }, 
      {
        "familyName": "Peterson", 
        "givenName": "Ellena M.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-4684-5856-5_3", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-4684-5858-9", 
        "978-1-4684-5856-5"
      ], 
      "name": "Medical Virology 9", 
      "type": "Book"
    }, 
    "keywords": [
      "intravenous drug abusers", 
      "adult T-cell lymphoma/leukemia", 
      "HTLV-I infection", 
      "human T-cell lymphoma/leukemia virus type I", 
      "human retroviruses", 
      "etiologic agent", 
      "cutaneous T-cell lymphoma", 
      "T-cell lymphoma/leukemia", 
      "immune deficiency states", 
      "HTLV-II infection", 
      "tropical spastic paraparesis", 
      "T-cell lymphoma", 
      "progressive neurological disorder", 
      "hairy cell leukemia", 
      "lymphoma/leukemia", 
      "virus type I", 
      "disease associations", 
      "autoimmune diseases", 
      "spastic paraparesis", 
      "immune deficiency", 
      "polymerase chain reaction", 
      "T cells", 
      "HTLV-II", 
      "rare case", 
      "cell leukemia", 
      "endemic areas", 
      "deficiency states", 
      "drug abusers", 
      "neurological disorders", 
      "HTLV", 
      "infection", 
      "leukemia", 
      "disease", 
      "host of diseases", 
      "chain reaction", 
      "patients", 
      "lymphoma", 
      "rural blacks", 
      "greater frequency", 
      "type I", 
      "retroviruses", 
      "association", 
      "myelopathy", 
      "paraparesis", 
      "arthritis", 
      "CD4", 
      "lupus", 
      "sarcoma", 
      "carcinoma", 
      "malignancy", 
      "anemia", 
      "agents", 
      "prevalence", 
      "disorders", 
      "abusers", 
      "United States", 
      "virus", 
      "deficiency", 
      "cases", 
      "Central Africa", 
      "host", 
      "limited homology", 
      "blacks", 
      "use", 
      "frequency", 
      "detection", 
      "quantification", 
      "time", 
      "countries", 
      "Japan", 
      "area", 
      "vertebrates", 
      "Africa", 
      "sections", 
      "homology", 
      "state", 
      "reaction", 
      "Caribbean", 
      "America", 
      "characterization", 
      "southeastern section", 
      "southern Japan"
    ], 
    "name": "The Use of the Polymerase Chain Reaction in the Detection, Quantification and Characterization of Human Retroviruses", 
    "pagination": "47-75", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1002987387"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-4684-5856-5_3"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-4684-5856-5_3", 
      "https://app.dimensions.ai/details/publication/pub.1002987387"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-08-04T17:15", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/chapter/chapter_164.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-1-4684-5856-5_3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-4684-5856-5_3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-4684-5856-5_3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-4684-5856-5_3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-4684-5856-5_3'


 

This table displays all metadata directly associated to this object as RDF triples.

184 TRIPLES      22 PREDICATES      107 URIs      100 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-4684-5856-5_3 schema:about anzsrc-for:11
2 anzsrc-for:1107
3 schema:author N3aac66cc5c694dea8baa3c17cdbd6358
4 schema:datePublished 1991
5 schema:datePublishedReg 1991-01-01
6 schema:description Retroviruses are the etiologic agents of a host of diseases found in vertebrates. These include malignancies such as lymphomas, leukemias, sarcomas and carcinomas; autoimmune diseases such as arthritis and lupus; and cytopathic diseases leading to anemias and immune deficiency states. There are four well characterized human retroviruses (Figure 1). Human T-cell lymphoma/leukemia virus type I and II (HTLV-I and II) are oncornaviruses. HTLV-I is believed to be the etiologic agent of adult T-cell lymphoma/leukemia (ATLL) and a progressive neurological disorder formerly called tropical spastic paraparesis and now termed HTLV-I associated myelopathy (HAM) (Bhagavati et al. 1988; Ehrlich and Poiesz 1988; Poiesz et al. 1980). HTLV-I is also associated with immune deficiency. HTLV-I infection is endemic in Southern Japan, the Caribbean and Central Africa. In the United States, HTLV-I infection is most prevalent in the Southeastern section of the country among rural blacks, but is has also been identified in patients throughout America and appears to be increasing in prevalence among intravenous drug abusers (IVDA) (Ehrlich and Poiesz, 1988; Ratner and Poiesz, 1988). HTLV-II is approximately 65% homologous to HTLV-I (Kalyanaraman et al. 1982). It has been associated with rare cases of T-cell and hairy cell leukemias, but its exact disease association and endemic area of infection are unclear at this time. HTLV-II infection is also being diagnosed with greater frequency in American IVDA (Ehrlich et al. 1989). HTLV-V is a recently described retrovirus with limited homology to HTLV-I (Manzari et al. 1987). It has been identified in a few patients with CD4+ cutaneous T-cell lymphoma, but the virus has not been completely characterized and its disease association is poorly understood.
7 schema:editor Nb679abcf954546a89176a645359a8f5a
8 schema:genre chapter
9 schema:isAccessibleForFree false
10 schema:isPartOf N68fbbd5b20fb4192b584b03f86d67bdf
11 schema:keywords Africa
12 America
13 CD4
14 Caribbean
15 Central Africa
16 HTLV
17 HTLV-I infection
18 HTLV-II
19 HTLV-II infection
20 Japan
21 T cells
22 T-cell lymphoma
23 T-cell lymphoma/leukemia
24 United States
25 abusers
26 adult T-cell lymphoma/leukemia
27 agents
28 anemia
29 area
30 arthritis
31 association
32 autoimmune diseases
33 blacks
34 carcinoma
35 cases
36 cell leukemia
37 chain reaction
38 characterization
39 countries
40 cutaneous T-cell lymphoma
41 deficiency
42 deficiency states
43 detection
44 disease
45 disease associations
46 disorders
47 drug abusers
48 endemic areas
49 etiologic agent
50 frequency
51 greater frequency
52 hairy cell leukemia
53 homology
54 host
55 host of diseases
56 human T-cell lymphoma/leukemia virus type I
57 human retroviruses
58 immune deficiency
59 immune deficiency states
60 infection
61 intravenous drug abusers
62 leukemia
63 limited homology
64 lupus
65 lymphoma
66 lymphoma/leukemia
67 malignancy
68 myelopathy
69 neurological disorders
70 paraparesis
71 patients
72 polymerase chain reaction
73 prevalence
74 progressive neurological disorder
75 quantification
76 rare case
77 reaction
78 retroviruses
79 rural blacks
80 sarcoma
81 sections
82 southeastern section
83 southern Japan
84 spastic paraparesis
85 state
86 time
87 tropical spastic paraparesis
88 type I
89 use
90 vertebrates
91 virus
92 virus type I
93 schema:name The Use of the Polymerase Chain Reaction in the Detection, Quantification and Characterization of Human Retroviruses
94 schema:pagination 47-75
95 schema:productId N84f7bb2cd5624ff097f5f30d05040abd
96 Ndb84371e33a84d1c8e615ce8e089ed65
97 schema:publisher N66626aa813354c088eb026faf4cc3d86
98 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002987387
99 https://doi.org/10.1007/978-1-4684-5856-5_3
100 schema:sdDatePublished 2022-08-04T17:15
101 schema:sdLicense https://scigraph.springernature.com/explorer/license/
102 schema:sdPublisher N4f8cf36787a04580bcfc95bbd6b58afc
103 schema:url https://doi.org/10.1007/978-1-4684-5856-5_3
104 sgo:license sg:explorer/license/
105 sgo:sdDataset chapters
106 rdf:type schema:Chapter
107 N38131121d2f846308f82e9c7fcb3d693 rdf:first sg:person.0723522010.54
108 rdf:rest N84ab611d8df349089ecf7dc7dd1d55e9
109 N3aac66cc5c694dea8baa3c17cdbd6358 rdf:first sg:person.014430643177.23
110 rdf:rest Ne55d7d12633b43d69e202f91ff20d867
111 N4f8cf36787a04580bcfc95bbd6b58afc schema:name Springer Nature - SN SciGraph project
112 rdf:type schema:Organization
113 N561eb54d4450430ab9cce0a94549d248 schema:familyName Peterson
114 schema:givenName Ellena M.
115 rdf:type schema:Person
116 N61667d793a004a61995ec50b63a6e1fd rdf:first N561eb54d4450430ab9cce0a94549d248
117 rdf:rest rdf:nil
118 N66626aa813354c088eb026faf4cc3d86 schema:name Springer Nature
119 rdf:type schema:Organisation
120 N68fbbd5b20fb4192b584b03f86d67bdf schema:isbn 978-1-4684-5856-5
121 978-1-4684-5858-9
122 schema:name Medical Virology 9
123 rdf:type schema:Book
124 N84ab611d8df349089ecf7dc7dd1d55e9 rdf:first sg:person.01027656121.75
125 rdf:rest Ne355aa7b4fcc4eb0860c22d67da25015
126 N84f7bb2cd5624ff097f5f30d05040abd schema:name doi
127 schema:value 10.1007/978-1-4684-5856-5_3
128 rdf:type schema:PropertyValue
129 N8e24330dd859494c9ec666c84037c4df rdf:first sg:person.01277046301.22
130 rdf:rest N38131121d2f846308f82e9c7fcb3d693
131 Nb679abcf954546a89176a645359a8f5a rdf:first Nd25f61ce4e674d4ca10171f3b1b80cd3
132 rdf:rest N61667d793a004a61995ec50b63a6e1fd
133 Nd25f61ce4e674d4ca10171f3b1b80cd3 schema:familyName de la Maza
134 schema:givenName Luis M.
135 rdf:type schema:Person
136 Ndb84371e33a84d1c8e615ce8e089ed65 schema:name dimensions_id
137 schema:value pub.1002987387
138 rdf:type schema:PropertyValue
139 Ne355aa7b4fcc4eb0860c22d67da25015 rdf:first sg:person.0632555710.46
140 rdf:rest rdf:nil
141 Ne55d7d12633b43d69e202f91ff20d867 rdf:first sg:person.01324252605.57
142 rdf:rest N8e24330dd859494c9ec666c84037c4df
143 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
144 schema:name Medical and Health Sciences
145 rdf:type schema:DefinedTerm
146 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
147 schema:name Immunology
148 rdf:type schema:DefinedTerm
149 sg:person.01027656121.75 schema:affiliation grid-institutes:grid.418424.f
150 schema:familyName Kwok
151 schema:givenName Shirley
152 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01027656121.75
153 rdf:type schema:Person
154 sg:person.01277046301.22 schema:affiliation grid-institutes:None
155 schema:familyName Byrne
156 schema:givenName Bruce C.
157 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277046301.22
158 rdf:type schema:Person
159 sg:person.01324252605.57 schema:affiliation grid-institutes:None
160 schema:familyName Ehrlich
161 schema:givenName Garth D.
162 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01324252605.57
163 rdf:type schema:Person
164 sg:person.014430643177.23 schema:affiliation grid-institutes:None
165 schema:familyName Poiesz
166 schema:givenName Bernard J.
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014430643177.23
168 rdf:type schema:Person
169 sg:person.0632555710.46 schema:affiliation grid-institutes:grid.418424.f
170 schema:familyName Sninsky
171 schema:givenName John
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632555710.46
173 rdf:type schema:Person
174 sg:person.0723522010.54 schema:affiliation grid-institutes:None
175 schema:familyName Wells
176 schema:givenName Keith
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723522010.54
178 rdf:type schema:Person
179 grid-institutes:None schema:alternateName Division of Hematology/Oncology, Health Science Center, State University of New York, 13210, Syracuse, New York, USA
180 schema:name Division of Hematology/Oncology, Health Science Center, State University of New York, 13210, Syracuse, New York, USA
181 rdf:type schema:Organization
182 grid-institutes:grid.418424.f schema:alternateName Cetus Corporation, 1400 Fifty Third Street, 94608, Emeryville, California, USA
183 schema:name Cetus Corporation, 1400 Fifty Third Street, 94608, Emeryville, California, USA
184 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...